|Bid||48.93 x 22800|
|Ask||48.95 x 59200|
|Day's Range||48.53 - 49.22|
|52 Week Range||25.68 - 64.58|
|Beta (5Y Monthly)||1.73|
|PE Ratio (TTM)||23.21|
|Earnings Date||Aug 13, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||May 24, 2019|
|1y Target Est||64.56|
Lanxess, whose ingredients are used in surface disinfectants, hand sanitizers and soaps, said growth in its consumer protection and specialty additives segments helped mitigate the impact of the outbreak in the first quarter. Chief Executive Matthias Zachert said that the ongoing second quarter has been hit by production closures in the auto industry, while going into the third quarter, the biggest impact would come from the wider economic climate as consumers are less likely to buy cars or electronics. The consumer protection segment, which includes antiviral disinfectants, will be one of the company's most resilient businesses, with its profitability likely to grow in 2020, he added.
Matthias Zachert became the CEO of LANXESS Aktiengesellschaft (ETR:LXS) in 2014. This report will, first, examine the...
Unfortunately for some shareholders, the LANXESS (ETR:LXS) share price has dived 44% in the last thirty days. Indeed...
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...
Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Lanxess AG and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers. This publication does not announce a credit rating action and is not an indication of whether or not a credit rating action is likely in the near future.
German chemical groups Bayer <BAYGn.DE> and Lanxess <LXSG.DE> have agreed to sell integrated chemical site operator Currenta to Macquarie Infrastructure and Real Assets (MIRA) <MQG.AX> for an enterprise value of 3.5 billion euros ($3.9 billion). Reuters reported last September initial plans by Bayer to divest its 60% stake in the chemical park operator, part of a string of assets it has put on the block to slash debt since its $63 billion takeover of Monsanto last year.